Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-Label, Multicenter Study to Characterise the Effects of Co-administration of MediDrink Platinum+ Formula Containing Novel Protein Blend SPR-01 and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

NCT07322653 is registered in ClinicalTrials.gov with Nuritas Ltd as lead sponsor.

NCT NCT07322653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07322653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-Label, Multicenter Study to Characterise the Effects of Co-administration of MediDrink Platinum+ Formula Containing Novel Protein Blend SPR-01 and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
Lead sponsor
Nuritas Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
September 10, 2025
Completion date
January 2, 2027
Enrollment
75 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malnourished, muscle mass, physical function, protein supplementation, sarcopenia in elderly, strength